Mahamaya Lifesciences Limited (BOM:544611)
165.65
-6.35 (-3.69%)
At close: Jul 23, 2026
42.80% (1Y)
| Market Cap | 3.89B |
| Revenue (ttm) | 3.29B +24.5% |
| Net Income | 165.23M +29.0% |
| EPS | 8.33 +10.4% |
| Shares Out | 23.41M |
| PE Ratio | 19.93 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,800 |
| Open | 170.00 |
| Previous Close | 172.00 |
| Day's Range | 165.25 - 170.00 |
| 52-Week Range | 111.00 - 205.05 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 1, 2026 |